Q32 Bio Inc. (FIXX) Operating income 2017–2025
Q32 Bio Inc. (FIXX) annual operating income history from SEC filings — each fiscal year as reported.
$16.9MFY2025 · since FY2017: -$29.7M → $16.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16.9M | +125.6% |
| FY2024 | -$66.1M | -37.0% |
| FY2023 | -$48.3M | +63.8% |
| FY2022 | -$133.3M | -38.9% |
| FY2021 | -$95.9M | +26.3% |
| FY2020 | -$130.3M | -18.5% |
| FY2019 | -$109.9M | -83.5% |
| FY2018 | -$59.9M | -102.1% |
| FY2017 | -$29.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice